At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 88 enrolled
Drug / intervention
DMTS +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy
In Brief
A Phase 2 clinical trial evaluating DMTS and Placebo for Pain, Postoperative. Completed, enrolled 88 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate whether the DMTS, compared with a placebo patch, will provide adequate pain relief during the first 3 days following bunionectomy surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesAustralia
CollaboratorsPremier Research
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartJan 2017
Primary CompletionJul 2017
TodayJul 2026
First PostedNov 2, 2016
Enrollment StartJan 22, 2017
Primary CompletionJul 3, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.7 years ago
Interventions
DMTSdrug
DMTS applied before surgery and worn for 72 hours
Placebodrug
Matching patches that have no active drug applied before surgery and worn for 72 hours.